Potentially damning email exchanges have been produced in a claim purchased by funder Henderson & Jones, which alleges Barclays helped a private healthcare company avoid paying compensation to women given faulty breast implants.
Manolete has released its half-year results, which have been impacted by an adverse judgment on one of its larger cases (which the Court of Appeal has agreed to review). Highlights include a tremendous six months for gross cash receipts from its completed cases of £15.7m, which is 269% higher than the comparable period last year, as well as a growth of 77% in realised revenues from completed cases and an increase of 34% in new case enquiries.
A £40m litigation case against Barclays could prove to be a gamechanger, opening the floodgates for creditors to pursue banks for questionable restructurings of companies which have since become insolvent and are unable to make creditors whole. Financed by funder Henderson & Jones, which purchased the claim from the liquidators of the Hospital Medical Group, the claim alleges that a restructure of the Group was illegally designed to defraud the Group’s creditors, including women who received illegally made and dangerous breast implants.